Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 8 Ovarian Neoplasms 7 Rectal Neoplasms 4 Colonic Neoplasms 4 Peritoneal Neoplasms 2 Pancreatic Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Robotic 1 Prostatic Neoplasms 1 Pancreatic Neuroendocrine Tumors 1 Ovarian Cysts 1 Neoplasms 1 Myofibroma 1 Kidney Neoplasms 1 Genital Neoplasms, Female 1 Gastrointestinal Stromal Tumors 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Endometrial Adenocarcinoma 1 Drug-Related Side Effects and Adverse Reactions 1 Diverticulitis 1 Crohn Disease 1 Colonic Polyps 1

Interventions

pembrolizumab 25 Gemcitabine 21 Nivolumab 17 Cisplatin 17 atezolizumab 14 Carboplatin 11 avelumab 9 vinflunine 7 Ipilimumab 7 Paclitaxel 6 Docetaxel 5 enfortumab vedotin 4 cabazitaxel 4 Pemetrexed 4 Mitomycin 4 cabozantinib 3 Taxes 3 Rogaratinib 3 Magnetic Resonance Spectroscopy 3 Injections 3 Albumin-Bound Paclitaxel 3 tremelimumab 2 sacituzumab govitecan 2 pemigatinib 2 niraparib 2 lenvatinib 2 bempegaldesleukin 2 apatorsen 2 XRP6258 2 Vitamin D 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Transitional Cell × Laparoscopy × Clear all

NCT03677544 2023-05-17

CYSTECTOMEN

Centre Hospitalier Universitaire, Amiens

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡